Know your preeclampsia risk — before it surprises you.

A simple blood test that reads thousands of signals from you, your baby and placenta — to give you and your care team time to implement a care plan early enough to reduce your risk.

Know your preeclampsia risk — before it surprises you.

A simple blood test that reads thousands of signals from you, your baby and placenta — to give you and your care team time to implement a care plan early enough to reduce your risk.

1 in 12 pregnancies are affected by preeclampsia.

It can become serious, fast. Preeclampsia can cause seizures, organ damage, preterm birth, and NICU stays — even in healthy pregnancies with no warning signs.

Introducing Encompass.

With Encompass^TM you and your care team are working from the same objective data, the conversation shifts from "let's wait and see" to "here's what we're doing and why."

Take control of your pregnancy journey.

If you are pregnant and will be age 35 or older at the time of delivery, ask your care team if you are eligible for Encompass.

Bring this guide to your next prenatal visit.

Download discussion guide

One clear result. One shared starting point.

Encompass reads thousands of signals from you, your baby, and the placenta. Powered by the Mirvie RNA Platform, this breakthrough RNA-science gives you and your care team time to implement an evidence-based preventive action plan early enough to help reduce your risk.

ELEVATED RISK RESULT

Work with your care team on a plan to help prevent preeclampsia, reduce its severity, delay its onset, or catch it right away.

Encompass correctly identified 9 out of 10 eligible pregnancies that developed preterm preeclampsia as “elevated risk.”

LOW RISK RESULT

Have clarity on the path ahead with a deeper understanding of your pregnancy's biology.

Those with a “low-risk” result have 99.7% probability of NOT developing preeclampsia between 20 and 37 weeks.

We accept all insurance, including Medicaid. We work to ensure cost is not a barrier to accessing predictive testing.
Insurance: We will submit claims on your behalf, though your deductible and cost share may apply.
Financial Assistance: We offer financial assistance for patients who qualify based on household income, provide flexible payment plans, and accept HSA/FSA.

Click here to find out what level of assistance you may qualify for:

Encompass billing guide

One blood draw at 17w 4d–22 weeks

A simple draw at your provider's office or mobile phlebotomist who comes to you. No extra visits, no complexity.

Results in 10–14 days

You receive a clear result, indicating either low or elevated risk, to guide your care forward with clarity.

A personalized action plan

If your risk is elevated, you and your care team will work on an action plan to reduce your risk, and you'll receive a home blood pressure monitoring kit and medication reminders.

Hear from mothers who have been there.

Get ahead of preeclampsia before it becomes a crisis.

"I was scared. I felt unprepared. My doctor even said I could have had a stroke or a heart attack."

Diane

Preeclampsia survivor

"I thought I had a healthy pregnancy until I went into my 34-week appointment and didn’t come home."

Amy

Preeclampsia survivor

Hear from mothers who have been there.

Get ahead of preeclampsia before it becomes a crisis.

"I was scared. I felt unprepared. My doctor even said I could have had a stroke or a heart attack."

Diane

Preeclampsia survivor

"I thought I had a healthy pregnancy until I went into my 34-week appointment and didn’t come home."

Amy

Preeclampsia survivor

Get Encompass for your pregnancy.

Ask your care team if you are eligible for Encompass. Bring this guide to your next prenatal visit.

Download the discussion guide

REFERENCES:

Elovitz MA et al. Molecular subtyping of hypertensive disorders of pregnancy. Nature Comms (2025)

Fink DA et al. Trends in maternal mortality and severe maternal morbidity. JAMA Network Open (2023)

Roberts J, et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gyn (2023)